Merrill Weber
Directeur Général chez VOTIS Subdermal Imaging Technologies Ltd.
Postes actifs de Merrill Weber
Sociétés | Poste | Début | Fin |
---|---|---|---|
VOTIS Subdermal Imaging Technologies Ltd.
VOTIS Subdermal Imaging Technologies Ltd. Medical SpecialtiesHealth Technology VOTIS Subdermal Imaging Technologies Ltd. is an Israeli corporation that develops a suite of devices to help diabetic patients keep their feet. The company is based in Jerusalem, Israel. The Israeli company's first device, PedCheck™, screens the feet of asymptomatic patients for PAD. If PAD is found, the second device, PedScan™, stages and monitors disease progression and the impact of therapies applied by the patient's physician. The third device, PedFlo™, informs the practicing doctor regarding the level of blood flow in the foot during a revascularization procedure. All three devices use the same technology, software, and system architecture, and are safe, non-invasive, and free of ionizing radiation. The company was founded in 2017 by Andreas H. Hielscher. Merrill Weber has been the CEO of the company since 2017. | Directeur/Membre du Conseil | 01/05/2017 | - |
Directeur Général | 01/05/2017 | - | |
President | 01/05/2017 | - |
Historique de carrière de Merrill Weber
Statistiques
Internationale
Israël | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
VOTIS Subdermal Imaging Technologies Ltd.
VOTIS Subdermal Imaging Technologies Ltd. Medical SpecialtiesHealth Technology VOTIS Subdermal Imaging Technologies Ltd. is an Israeli corporation that develops a suite of devices to help diabetic patients keep their feet. The company is based in Jerusalem, Israel. The Israeli company's first device, PedCheck™, screens the feet of asymptomatic patients for PAD. If PAD is found, the second device, PedScan™, stages and monitors disease progression and the impact of therapies applied by the patient's physician. The third device, PedFlo™, informs the practicing doctor regarding the level of blood flow in the foot during a revascularization procedure. All three devices use the same technology, software, and system architecture, and are safe, non-invasive, and free of ionizing radiation. The company was founded in 2017 by Andreas H. Hielscher. Merrill Weber has been the CEO of the company since 2017. | Health Technology |
- Bourse
- Insiders
- Merrill Weber
- Expérience